TCIRG1
protein-codingT cell immune regulator 1, ATPase H+ transporting V0 subunit a3, the group of V-type ATPase subunits|MicroRNA protein coding host genes
Gene summary
This gene encodes a subunit of a large protein complex known as a vacuolar H+-ATPase (V-ATPase). The protein complex acts as a pump to move protons across the membrane. This movement of protons helps regulate the pH of cells and their surrounding environment. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. V-ATPase is comprised of a cytosolic V1 domain and a transmembrane V0 domain. Alternative splicing results in multiple transcript variants. Mutations in this gene are associated with infantile malignant osteopetrosis. [provided by RefSeq, May 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019026
Submitter: Myriad Women's Health
Inheritance Pattern: AR
Disease ID:MONDO:0009138
Submitter: ClinGen
TCIRG1 was first reported in relation to Autosomal Recessive Dysosteosclerosis in 2019 (Howaldt et al., PMID: 30537558). Dysosteosclerosis is a rare genetic primary bone dysplasia disease characterized by sandwich vertebrae, progressive osteosclerosis and platyspondyly. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, there was evidence of differences in phenotypic spectrum of the disease assertions with this gene. Therefore, the following disease entities have been split into multiple disease entities: Autosomal Recessive Osteopetrosis 1 (MONDO:0009815) and Dysosteosclerosis (ORPHA: 1782). The split curation for autosomal recessive Osteopetrosis 1 (OMIM:259700) has been curated separately. This curation is for autosomal recessive Dysosteosclerosis. Two variants (1 frameshift, 1 splice region) that have been reported in a family consisting of 2 affected siblings in 1 publication (PMID: 30537558) are included in this curation. The mechanism of pathogenicity is presumed to be loss of function though more evidence is required. This gene-disease association is also supported by expression data. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date 12/4/23 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0012679
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009815
Submitter: Natera
Inheritance Pattern: AD
Disease ID:MONDO:0008742
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009138
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019026
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009815
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009815
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009815
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009815
Submitter: ClinGen
*TCIRG1* was first reported in relation to autosomal recessive Osteopetrosis 1 in 2000 (Frattini et al., PMID:10888887). Osteopetrosis is caused by subnormal osteoclast function that typically manifests in the first few months of life. It is characterized by: abnormally dense bone, macrocephaly and frontal bossing, tooth defects, feeding difficulties, visual and hearing loss, bone marrow insufficiency, severe anemia, and hepatosplenomegaly. At the time of this curation, there were no other single-gene disorders associated with this gene. This curation is based on this disease entity only. 24 variants (missense, splice site, frameshift, nonsense) that have been reported in 12 probands in three publications (PMIDs: 11532986, 10888887, 34545712) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. This gene-disease association is also supported by animal models, expression studies, and functional alteration studies (PMIDs:10888887,19448635,11532986, 10709991). In summary, *TCIRG1* is definitively associated with autosomal recessive Osteopetrosis 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date 03/01/23 (SOP Version 9).
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Dental; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Hematologic; Musculoskeletal
Rationale: Although the disorder may be frequently recognizable, medical treatments (eg, calcitriol, interferon gamma-1b) as well as surgical interventions may be beneficial; Early and aggressive treatment of infectious and hematologic manifestations, as well as neonatal hypocalcemia, which can result in tetanic seizures, may be beneficial; Awareness of multi-organ system complications may allow surveillance and prompt interventions; BMT/HSCT has been described
Comments: Milder forms of disease, possibly due to heterozygous variants have been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TCIRG1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006019.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 22 | 485 | 508 | ||
| missense | 3 | 19 | 530 | 30 | 3 | 585 |
| nonsense | 27 | 30 | 2 | 59 | ||
| start loss | 0 | |||||
| frameshift | 54 | 83 | 4 | 141 | ||
| splice donor/acceptor (+/-2bp) | 17 | 51 | 5 | 1 | 74 | |
| Total | 101 | 184 | 563 | 516 | 3 | 1367 |
Highest pathogenic variant AF is 0.00029316862
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006010.2 | 19 | MANE Select | |
| Ensembl | ENSP00000265686.3 | 19 | MANE Select | |
| RefSeq | NP_001337988.1 | 12 | Standard | |
| RefSeq | NP_001427481.1 | 19 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Synaptic vesicle cycle - Homo sapiens (human)
- Phagosome - Homo sapiens (human)
- Lysosome - Homo sapiens (human)
- Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human)
- Oxidative phosphorylation - Homo sapiens (human)
Biological Process
- cellular defense response
- vacuolar acidification
- protein catabolic process in the vacuole
- positive regulation of cell population proliferation
- insulin receptor signaling pathway
Molecular Function
- transporter activity
- proton-transporting ATPase activity, rotational mechanism
- ATPase binding
Cellular Component
- vacuolar proton-transporting V-type ATPase, V0 domain
- lysosomal membrane
- plasma membrane
- integral component of plasma membrane
- endosome membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000265686
- Coding exons
- 19
- Length
- 11880
- Individuals with no LoFs
- 125630
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 116
- Defined
- 125746
- p
- 0.000461
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.627 | 489 | 530 | 0.923 | 0.0000379 | 5307 |
| Missense (PolyPhen) | 189 | 223.42 | 0.84596 | 2400 | ||
| Synonymous | -0.468 | 247 | 238 | 1.04 | 0.0000177 | 1752 |
| Loss of Function | 2.26 | 27 | 43.0 | 0.628 | 0.00000242 | 409 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00035 | 0.00035 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00038 | 0.00038 | rare |
| Finnish | 0.00045 | 0.00042 | rare |
| European (Non-Finnish) | 0.00058 | 0.00057 | rare |
| South Asian | 0.00046 | 0.00046 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Part of the proton channel of V-ATPases (By similarity). Seems to be directly involved in T-cell activation. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.386
Intolerance Scores
- LoFtool
- 0.0490
- RVIS EVS
- -1.12
- RVIS percentile EVS
- 6.58
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.396
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |